NanoViricides
NNVC
#10348
Rank
$32.17 M
Marketcap
$1.40
Share price
4.48%
Change (1 day)
-2.10%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : $8.35 Million USD

According to NanoViricides's latest financial reports the company's total assets are $8.35 Million USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2025-06-30$8.82 M-31.18%
2024-06-30$12.82 M-24.12%
2023-06-30$16.89 M-28.07%
2022-06-30$23.49 M-22.36%
2021-06-30$30.26 M26.54%
2020-06-30$23.91 M77.82%
2019-06-30$13.44 M-27.49%
2018-06-30$18.54 M-31.32%
2017-06-30$27 M-26.29%
2016-06-30$36.63 M-17.09%
2015-06-30$44.18 M0.75%
2014-06-30$43.85 M167.32%
2013-06-30$16.4 M4.98%
2012-06-30$15.62 M45.28%
2011-06-30$10.75 M19.64%
2010-06-30$8.99 M199.62%
2009-06-30$3 M104.41%
2008-06-30$1.46 M8.74%
2007-06-30$1.35 M-50.53%
2006-06-30$2.72 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
$56.27 B 673,317.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$128.68 B 1,539,732.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$86.47 B 1,034,663.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$83.25 B 996,171.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
$1.04 B 12,382.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.46 B 5,464.77%๐Ÿ‡บ๐Ÿ‡ธ USA